MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial

The Lancet Oncology

Fecha de publicación: 17 June 2019

DOI: https://doi.org/10.1016/S1470-2045(19)30275-X

Autores: Sepideh Saadatmand, MD., H Amarens Geuzinge, MSc.,
Prof Emiel J T Rutgers, MD., Ritse M Mann, MD., Diderick B W de Roy van Zuidewijn, MD., Harmien M Zonderland, MD., et al.

Background: Approximately 15% of all breast cancers occur in women with a family history of breast cancer, but for whom no causative hereditary gene mutation has been found. Screening guidelines for women with familial risk of breast cancer differ between countries. We did a randomised controlled trial (FaMRIsc) to compare MRI screening with mammography in women with familial risk.